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INTRODUCTION 
 
Nanotechnology is science’s next big thing.  It’s the tiny world of controlling matter at 
the scale of one billionth of a meter, or less than one-100,000th the width of a human 
hair.  Researchers are exploring ways to see and build at this scale, reengineering 
familiar substances like carbon and gold to create new materials with novel properties 
and functions.   
 
In just a few short years, nanotechnology has catapulted from being a specialty of a few 
physicists and chemists to a worldwide scientific and industrial enterprise.  The National 
Science Foundation predicts that the global marketplace for goods and services using 
nanotechnologies will grow to $1 trillion by 2015, and there are already over 500 
products being sold that claim they are made with nanoscale or engineered 
nanomaterials.  These include products like self-cleaning windows, automobile paint, 
sunscreens, and tennis rackets.  In the future, a marriage of nano and biotechnology 
will likely create a whole new generation of drugs, biomedical devices, and other 
solutions to some of our most challenging medical problems.   
 
But little is known about the technology’s possible health and environmental 
implications.  The federal government is just beginning to develop regulatory 
approaches specific to nanotechnology applications and production.  At this critical 
juncture, it is important that leaders from industry, government, the science and 
engineering community, and other sectors develop a better understanding of what the 
public wants and expects in terms of the oversight of these new and emerging 
technologies. 
 
This report, “Informed Public Perceptions of Nanotechnology and Trust in Government,” 
could not come at a more propitious time.  It provides an in-depth look at what 
Americans know and do not know about nanotechnology.  It offers a view of the nano 
applications and products people think are most important.  It examines who Americans 
trust most to manage nanotechnology’s potential risks.  And it highlights what particular 
concerns citizens may have about nanotechnology’s use.  
 
For me, the most important message from this report is that a lack of information—
about nanotechnology-based products, about their possible health and environmental 
implications, and about the oversight processes designed to manage risks—breeds 
public mistrust and suspicion.  This report shows that in the absence of balanced 
information, people are left to speculate about the possible impacts of nanotechnology.  
They often draw on analogies to past technologies, many of which may be misleading, 
such as asbestos, dioxin, Agent Orange, or nuclear power.   
 
Consumers want more information to make informed choices about nanotechnology’s 
use, and they strongly support more research and safety testing before products go to 
market.  When asked whether they felt voluntary standards for industry would be 
sufficient to manage the potential risks of nanotechnology, 55 percent of study 
participants said that mandatory government controls are necessary.  An additional 33 
percent were unsure whether voluntary standards would be sufficient.  Government and 
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industry need to realize that while voluntary measures may be pursued in the short 
term, they may not assuage public concerns over the long term.   
 
After taking part in the issue groups we conducted, half the participants felt mostly or 
quite positive about nanotechnology, and 32 percent remained neutral.  Traditionally, 
the public is willing to accept risks associated with new technologies if there is clear 
evidence of early, significant new benefits like low cost, highly efficient solar energy or a 
breakthrough treatment for Alzheimer’s disease.   
 
For nanotechnology, those significant benefits are still largely a promise.  Until they are 
delivered, expect a certain degree of public skepticism about the next big thing. 
 
 
 
David Rejeski 
Director, Project on Emerging Nanotechnologies
Washington, DC 
September 2005 
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Executive Summary 
 
This report presents results of a study, conducted May through June of 2005, on the 
public’s perceptions of government, nanotechnology, and regulation.  The study was 
designed in response to a number of questions that emerged from a 2004 study, which 
found low levels of public trust in government to manage potential risks associated with 
nanotechnology.  In this study, we wanted to learn more about why this low level of 
trust exists.  Is there simply a general public mistrust in government or is it related to 
individual government agencies or particular applications of nanotechnology?  More 
specifically, we wanted to find out what steps government and industry could undertake 
to improve trust. 
 
Using a highly structured research approach, we formed groups consisting of private 
citizens in Cleveland, Dallas, and Spokane, and provided them with balanced, clearly 
written information on nanotechnology and on U.S. regulatory and policy-making bodies 
relevant to nanotechnology.  The information packets included four sets of briefing 
materials to explain applications of emerging nanotechnologies, including such areas as 
consumer and personal product applications and products created by the convergence 
of biotechnology and nanotechnology.  
 
Our findings suggest the following general public perceptions, which are detailed in the 
body of the report and presented in table format in the Appendix.  
 
“It sounds like a 
great idea. It can 
help everything.” 
• Major Benefits Are Anticipated. The top two anticipated benefits from 
nanotechnology are major medical advances and improved 
consumer products, which accounted for 31% and 27% of all the 
benefits identified, respectively.  General technological progress 
was also seen as a significant benefit, as were advances in 
environmental protection, lower cost energy, and improved food 
and nutrition.  
 
• Public Wants To be Included.  The need for a voice for the public and the 
lack of information available to consumers about technology decision-making 
were strong threads throughout the study.  Participants 
were concerned about the existence of hundreds of 
nanotechnology-enabled products in the marketplace 
and the expenditure of billions of dollars of taxpayer 
money on nanotech R&D without public involvement.  
Participants presented an overarching desire to both be 
informed and to have a role in decision-making.  “We 
need to be informed,” demanded one participant while ano
“government should not be making these decisions alone,”
to medicine and to food.  
 
• Lack of Support for a Ban on Nanotechnology Produ
governmental group has advocated that new nanotechnolo
banned until further study of the potential risks. After learn
 3“One of the drawbacks of 
nanotechnology is that there are 
going to be a lot of people out there 
who are scared because they don’t 
know what it is, and are going to slow 
the technology down.” ther stated that 
 especially as it relates 
cts. One non-
gy products be 
ing about 
nanotechnology and its applications, 76% of respondents believe “a ban is 
overreacting.”  
 
“Nanotechnology can be 
good, if regulated 
properly.” 
• High Demand for Effective Regulation.  The majority of 
study participants felt that voluntary safety standards applied 
to industry would not be sufficient to manage the potential 
risks associated with nanotechnology; 55% said government 
control beyond voluntary standards is necessary, while 33% were unsure.  Only 
11% felt voluntary standards would be adequate.   Even given their regulatory 
concerns, 50% felt positive or quite positive after learning about nanotechnology 
and the differing roles of the regulatory agencies, while 32% remained neutral. 
 
“Regulators are affected by 
politicians… Politicians are 
influenced by lobbyists.” 
• Low Public Trust in Government.  As in the earlier 
study, low trust in government to manage technology-
related risks was still prevalent.  It appears to be related, 
first, to specific regulatory agencies and other entities of 
government, and second, to specific applications of nanotechnology. Trust in 
regulatory agencies seems to reflect past history with certain categories of 
products, e.g., the Federal Drug Administration’s difficulty with the drug Vioxx. 
Public trust was lowest vis-a-vis the Congress and the White House.  Study 
participants felt political pressure has in the past interfered with protections for 
public safety.  Regulatory agencies were thought to be trying to do their job to 
ensure public safety, but limited by outside pressure from providing appropriate 
levels of protection.  
 
• Suspicions of Industry. Past safety issues with specific 
products, ranging from drugs to genetically engineered 
crops, have led to a widespread perception that industry 
pushes products to market without adequate safety 
testing, makes too many errors affecting people’s health, 
and puts its own motives ahead of consumer safety. In gene
felt there are “unscrupulous risks taken by the medical comm
there exists “a race with too many mistakes.” 
 
• Specific Recommendations on How to Improve Trust.
surprising degree of agreement among participants on how g
industry could improve trust.  These were: (1) through more
products were introduced and (2) the provision of more infor
public..  One participant observed “[there is] a past history o
and most participants supported a more “thorough investigat
release.” 
 
• Media Influence is Presently Low.  Study participants kn
nanotechnology prior to the study.  Of those who had heard 
source, 22% said it was from public television or radio, and 2
had heard about nanotechnology from another person (word
media channels seem to be having little impact on awarenes
commercial news media is not a primary source of informatio
 4“I’m all for it if it makes my life 
easier, but it is like Vioxx – the 
world is in a rush, rush, rush, to 
get it out there.”ral the participants 
unity,” and overall 
   There was a 
overnment and 
 testing before 
mation to the 
f failed precautions,” 
ion before [product] 
ew little about 
of it from one 
0% indicated they 
-of-mouth).  Popular 
s, while for most, 
n. 
Background 
 
In 2004, the National Science Foundation provided funding for two separate explorations 
of citizen perceptions of nanotechnology.  First, a national survey explored issue 
framing, trust in government to manage risks, and expectations of benefits versus risks 
from nanotechnology.  Awareness of nanotechnology, attitudes towards it, and the 
present effect of science fiction films and novels such as Michael Crichton’s recent book 
Prey also were investigated (Cobb & Macoubrie, 2004).  
 
Second, a separate study was designed to investigate the reactions of informed citizens.  
This study used experimental issue groups (EIGs) where citizens in three different cities 
were provided with background materials on nanotechnology and scenarios depicting 
possible developments projected for nanotechnology.  Several forms of data were 
collected from the EIGs, including questionnaire data on attitudes towards 
nanotechnology, levels of concern for risk, trust in government and industry to manage 
risks, individual level reflections and insights, and demographic data for the participants 
(Macoubrie, in press).   Major findings of the 2004 studies:  
 
• The national survey, which sampled 1,250 people, found high interest in 
anticipated benefits from nanotechnology. Many people had only heard the word 
nanotechnology, however, little knowledge has penetrated through the media to 
the general public.  
• The highest interest was in medical applications, particularly to target disease 
without invasive surgery, collateral damage, or side effects.  However, in two 
regions of the country (West Coast and Midwest), these applications also evoked 
the lowest trust in government to manage the risks. 
• The public was not at all certain benefits would exceed risks.  In fact, 22% 
believed risks would exceed benefits, while 38% expected risks and benefits to 
be about equal; 40% believed benefits would exceed risks.  
• In the experimental groups that were conducted involving 152 people, 95% of 
the participants expressed little or no trust in government to effectively manage 
the possible risks associated with nanotechnology. In the national survey, 95% 
of those surveyed did not trust industry leaders to effectively manage any risks.   
The similarity of these results was striking. 
• In the 2004 experimental study examining concerns about nanotechnology and 
reasons for them, concerns were dominated by experiential knowledge. Rather 
than true unknowns, possibilities that neither scientists nor citizens can predict, 
concerns were based on knowledge of past technological “breakthroughs” from 
which significant downsides later emerged.  
• The public did not seem to be fearful of nanotechnology itself, but is highly 
aware of past failures to gauge and manage risks found to be associated with 
other new technologies.  
• World military and “evil doer” risks were mentioned the most, followed by 
concerns about long-term health risks and environmental impacts. 
• Finally, higher education (college degree or higher) was related to low trust in 
government to manage any risks.  No other demographic variable showed any 
significant link. 
 
 5
Overview of this Study 
 
A more detailed description of the study design is provided in the Appendix. This section 
provides a sketch of the methods in areas that may be of most interest to readers. To 
study informed citizens’ perceptions and attitudes, information was provided to 
participants about existing and emerging nanotechnology applications in areas such as 
consumer products, medicine, and agriculture.  One group received materials that 
discussed the anticipated convergence of nanotechnology and biotechnology and its 
uses to enhance the human body.  In all, 12 groups with a total of 177 participants were 
gathered together in 3 different locations: Spokane, Washington; Dallas, Texas; and 
Cleveland, Ohio.  
 
Following known best practices of science journalists, the 
background materials were developed to present a balanced 
view of known and projected applications of nanotechnology. 
Brief information also was included on the roles of six regulatory 
agencies, as well as Congress and the White House, involved (or 
potentially involved) in nanotechnology oversight. The materials 
were reviewed by scientists and regulators for accuracy, balance, 
and clarity and were written to be understandable by a lay audience.  Materials focused 
on conveying known facts and the reasoning about important issues rather than merely 
stating opposing positions.  The data analysis reported here was conducted by Dr. Jane 
Macoubrie.  
 
Study pre- and post-test questionnaire, informational materials, and additional details of 
the study methodology are given in the Appendix of this report. Study participants were 
recruited to be representative of demographics in the 3 locations chosen for the study.  
The primary characteristics of the study participants relative to the 2000 Census are 
shown below.  
 
2005 Study Participants 
 Political 
Affiliation Gender % Race % 
Mean 
Income 
Mean 
Age EDU % 
 
 M F Cauc Afr.Am. Hisp./ Latino 
Native 
American 
& Other 
   
Study 
Sample  
R=30% 
D=37% 
Ind=25% 
Other=8
% 
49.2 49.2 58.8 20.3 14.7 5.1  43 
HS=22* 
SC=26 
TRD/CERT=10 
CD=23 
>CD16 
 
2000 US 
CENSUS 
 49 51 77 13 4.2  50K 35.3 
HS=27 
SC=21 
CD=26 
>CD=9 
EDU: HS = high school diploma, SC = some college, TRD = trade or certificate training beyond 
HS, CD = college degree, >CD = education beyond 4 year degree. *Less than HS = 2.3%. 
Missing data = 1.1%.  
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Results of this study are from an analysis of three forms of data:  
 
1) answers to survey questions in pre- and post-test questionnaires,  
2) individual-level data provided in response to opportunities to privately express 
areas of concerns and benefits, prior to group discussion, and  
3) group discussion of concerns, benefits, and perceptions of regulatory 
agencies.  
 
Pre-test survey questionnaires were administered prior to the study. After reading the 
informational materials, individuals then gave responses to ‘concerns’ and ‘anticipated 
benefits’ of nanotechnology, discussed specific issues in their group, and finally, 
completed a post-study questionnaire. Some questionnaire items were included in both 
pre- and post-test; others were only asked in post-test, as appropriate.  
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Full Study Results 
 
This section of the report summarizes the findings and uses examples of participants’ 
comments or statements of concerns/benefits to illustrate the results. Data tables of full 
results are given in the Appendix. 
 
General Attitudes and Knowledge 
 
• Low Awareness of Nanotechnology: As in the 2004 studies, most people 
participating in the study had little initial awareness of nanotechnology. 
Answering the pre-study questionnaire, 54% professed to know almost nothing, 
17% felt they knew something about nanotechnology, and 26% said they knew 
a little. Asked if nanotechnology is predicted to become another industrial 
revolution (true), 75% said “don’t know” and 24% answered “true.” [See Tables 
1 and 2, Appendix] 
 
• Varied Sources of Knowledge: Study participants were also asked about the 
sources of their information on nanotechnology, if they had any prior knowledge.  
When respondents identified only one source of knowledge, 22% said they had 
heard about nanotechnology from public television or radio, and 20% said they 
had heard about nanotechnology from another person. 14% had heard of 
nanotechnology from commercial television or radio news, 10% from science 
fiction, 8% from magazines and 8% from newspapers. If respondents had heard 
of nanotechnology from two sources, 28% mentioned magazines, 17% hearing 
from another person, 14% from science fiction, 11% from trade journals, and 
another 11% from public television or radio. [See Table 3, Appendix] 
 
• Generally Positive Attitude towards Nanotechnology:  Initial attitudes 
towards nanotechnology prior to the study were investigated by asking “are you 
quite positive, mostly positive, neutral, mostly negative, or don’t know 
concerning your feelings about nanotechnology?”  Initially, 38% were neutral, 
13% were mostly positive, 41% answered “don’t know,” and less than 9% were 
either quite positive or mostly negative. After the study, 50% were mostly or 
quite positive, 32% remained neutral, 13% were mostly or quite negative, and 
3% answered “don’t know.” [See Table 4, Appendix] 
 
• Benefits will Exceed Risks: Perceived risks of nanotechnology versus 
nanotechnology’s benefits were also tested in pre- and post-study questionnaire. 
After the study, 41% said the benefits should exceed the risks, 30% believed the 
risks and benefits would be about equal, 15% expected risks to exceed benefits, 
and 14% answered “don’t know.” [See Table 5, Appendix] 
 
• Little Support for a Ban:  After they had learned about nanotechnology, 
participants were asked: “Should nanotechnology be banned until further study 
of possible risks?”  76% of the respondents said “a ban is overreacting.”  An 
additional 16% said “don’t know;” 8% supported a ban of new nanotechnology 
products. [see Table 6, Appendix] 
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Respondents’ Interests in Nanotechnology Benefits 
 
After reading informational materials on one of the four emergent applications areas of 
nanotechnology, study participants were asked to identify up to 5 areas of highest 
interest regarding the potential benefits of nanotechnology. These areas were written 
individually by study participants on a 5”x7” card, one benefit listed per card. The 
benefits of interest were clustered together as types of benefits (e.g., “treat cancer,” 
“reduce overuse of antibiotics,” “a cure for Alzheimers,” “could lead to a cure for 
HIV/AIDS,” are grouped in the benefit category of major medical uses).  See the 
Appendix for more information on the analytic method used to summarize concerns and 
benefits.  
 
1. Medical Applications of Greatest Interest: Study participants named as 
the top type of benefit major medical advances possible through 
nanotechnology (31% the of benefits identified).  This included a wide range 
of possible applications from new diagnostic methods to treatments for 
cancer and diabetes. 
 
2. Better Consumer Products: The second most frequently mentioned 
benefit group (27%), the consumer product category, contains potential 
benefits like “less toxic paint coatings,” “toothpaste to fill cavities,” “make life 
easier,” “trash bags that biodegrade” and “stain resistant clothing.”  
 
3. General Progress. Benefits related to general progress account for 12% of 
benefits identified (general advancement - 5%, human race progress - 2%, 
and general knowledge advancement - 5%).  
 
4. Environmental Protection: Environmental protection ranked fourth (8%) 
in benefits mentioned and includes such things as “less contaminated water,” 
“stop damage to the planet,” and “reduce waste, use less materials.”  
 
5. Safer and Better Food: Food and nutrition benefits, the 5th most 
frequently named benefit (6%) includes “safer food,” (from smart 
packaging), “more nutritious food,” and the ability to “feed the world.”  
 
6. Energy, Economy, Electronics: Energy benefits, the economy, and 
improved electronics and computing each garnered 4% of benefits 
envisioned. 
 
7. Benefits to Soldiers, Security. Military uses and national security were 
mentioned in 3% of benefit comments.  
 
N = 349 benefits named by 177 participants Percentage 
Major medical uses 31 
Consumer products 27 
General progress* 12 
Environmental protection 8 
Food and nutrition 6 
Economy, jobs 4 
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Energy 4 
Electronics, computers 4 
Military uses and national security 3 
Advancing international welfare 1 
   *Knowledge advancement 5%, Advance society 5%, Human race progress 2% 
 
 
Specific Concerns About Nanotechnology 
 
Study participants were invited to identify areas of concern separately from benefits.  
Areas of concern were written individually by study participants on a 5”x7” card, one per 
card, and later, categorized as they fell cumulatively into particular types of concern.  
 
• High Level of Concern about Unknowns, Regulation, and 
Health Risks: The three top-ranking concerns -- true unknowns, 
regulation, and human health risks – accounted for almost 40% of 
the total concerns mentioned. The true unknowns label applies to 
concerns identified where outcomes and effects cannot be 
predicted by anyone, including nanoscientists. This category 
includes concerns such as “unknown risks and consequences,” 
“unintended uses,” ”how our manipulation will effect natural laws,” and 
“unpredictability if nano follows its own natural laws.” 
 
• Long-term Effects: Also high on the list of concerns 
were those relating to the need to better understand and 
mange potential long-term effects. Concerns identified 
included “thorough investigation before release,” 
“standards…past history of failed precautions,” “you 
aren’t talking about the long-term effects…why not?” and “sh
substantial research on long-term effects.” 
 
• Human Health Risks are Important: Human health conc
statements such as “cell effects that lead to cancer, like in th
uses it could go where it shouldn’t,” “immune system respon
parts that just fail later,” and “medically untested cures.”  
 
• Concerns Affected by Past Problems: Examples of past 
regulatory, environmental, and human health errors, given to
support concerns in several categories, included Vioxx, Viagr
Phen Fen (dietary pills), DDT, asbestos, nuclear power, lead 
gasoline, jet fuel contaminating military bases, and genetical
 
• Playing God:  Playing God and messing with nature include
products that cause harm,” “trying to outthink God…it won’t 
better,” “don’t mess with nature,” “leave DNA alone, don’t pl
consumer, I want purity, not chemicals.” While this was a co
individually by 5% of respondents, this concern was reiterate
discussion by a small but vocal minority.  
 
 10“What effect does it have on the 
environment?  What happens if they 
don’t break down?  How do we get 
rid of them?  We don’t want to find 
out in 20 years that it causes cancer.”ould have 
erns included 
e past,” “in medical 
ses,” “lab-created 
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• The Need for Effective Regulations:  The regulatory category includes 
concerns for both ineffective and potentially over-restrictive regulations. 
Participants spoke about “politics getting into regulation,” “who regulates the 
regulators, like with biopharming,”  “lack of regulation during development,” 
“must be regulated sufficiently,” “that government can be manipulated to get the 
effect desired,” “if too many regulate, nothing will get done,” as well as “whether 
it will be over-regulated” and “over regulation leaving U.S. in the dust, like with 
stem cells.”  
 
• Military Uses and Abuses: Concerns over military uses ranged 
from “bad guys with progressive tools,” to “keep our soldiers safer,” 
“use to fight terrorism,” and include concern about “international 
competition with negative effects,” as well as “a new arms race” and 
“no military applications…I don’t’ trust this.”  
 
• In My Food?: Nanotechnology’s use in food products, packaging, 
and agriculture led to food chain concerns, including “long term 
consumption of nano food,” “adulterated field crops,” “natural 
agriculture and animals,” “foods that metabolize to worsen health,” 
“biopharming in the wrong hands could be disastrous,” and “using live pe
experiments with FDA approval.”  
 
• Consumer Information: Consumer knowledge and information concer
included “what say will the public have?” “government alone should not b
making these decisions,” “who gets a say in regulation?” “lack of knowled
disclosure to users,” “we should know when food is affected by nano and
the risks,” and “we need to be informed when nanotechnology is in some
like cosmetics.”  
 
• People Centered Goals: People centered goals for progress include 
concerns like “can we trust government to make decisions for the good 
of people and not just $$,” “moral implications of nano medicine…extent
of its use and by whom?” and that we “should study moral and social gu
more.”  
 
 
N = 426 concerns identified by 177 participants Percentage 
True unknowns 13 
Regulatory concerns 13 
Human health risks 13 
Testing and research for safety 12 
Effect on environment 10 
Food & food chain concerns 7 
Industry irresponsibility 7 
Privacy 6 
Military uses, international political instability 6 
Playing God, messing with Mother Nature 4.5 
Economic access & education 4 
 11“[Nanotechnology] 
could create weapons 
worse than nuclear.” “I have reservations 
as far as its use in 
food, animals, in the 
chain that we eat.” 
ople for 
ns 
e 
ge & 
 be told 
thing 
“We’re gonna be 
killed or cured.” 
 
idelines 
Consumer knowledge & information 3 
People centered goals for progress 2 
Taxpayer cost of development 1 
Fearful people stopping good 1 
Mistrust of government in general  1 
Social upheaval & adjustment .5 
 
 
Trust in Regulatory Agencies, Political Entities, and Industry  
 
One purpose of this study was to discover more about the sources of low trust in 
government in relation to nanotechnology. The 2004 study had found low levels of trust, 
largely based on experience with earlier technologies, in which situations arose where 
too little knowledge of products later led to environmental and human health problems.  
Examples given in 2004 included asbestos, dioxin, lead paint, Prozac accumulating in 
bodies of water, PCBs, and Agent Orange. 
 
To determine if low trust in government is related to any specific entity, questions in 
both the entry survey questionnaire and the post-test were asked in relation to different 
regulatory agencies: “Even if there are risks with nanotechnology, I trust the (…..) to 
effectively manage these risks.” The agencies and political entities tested for association 
with low trust were the Congress, White House, Food and Drug Administration (FDA), 
Occupational Safety and Health Administration (OSHA), Centers for Disease Control 
(CDC), Consumer Product Safety Commission (CPSC), Environmental Protection Agency 
(EPA), and United States Department of Agriculture (USDA). Congress and The White 
House were included simply to include a wide variety of political entities that might 
affect nanotechnology policy and regulation.  After participants had read about 
nanotechnology applications and regulatory responsibilities, as well as completed other 
parts of the study, the trust questions were asked again in order to measure trust in 
regulatory entities related to nanotechnology.  
 
Results concerning trust in government indicate that low trust is related specifically to 
(1) particular federal agencies, and (2) to specific applications of nanotechnology. There 
also were a number of other interesting findings: 
 
• Low Initial Awareness of the Role of 
Government Agencies:  In the pre-test (the 
questionnaire given prior to reading informational 
materials on nanotechnology and regulatory 
agencies), 33% to 46% said they did not know if 
the FDA, EPA, USDA, White House, or Congress, 
etc., would effectively manage risks.  This uncertainty c
after participants received information on both nanotec
responsibilities. 
 
• Low Trust in Congress and the White House: Con
House received lower initial trust responses compared t
40% and 38% ‘disagree’ or ‘strongly disagree’ these en
 12“I found it interesting so many 
government agencies are potentially 
responsible [for nanotechnology].  With 
so many agencies, bureaucracy hinders 
the process because everybody is 
fighting over who is responsible.” hanged in the post-test, 
hnology and regulatory 
gress and the White 
o regulatory agencies: 
tities could be trusted to 
effectively manage any risks, while 25% and 29%, respectively, agreed or 
strongly agreed that these entities were trustworthy.  
 
• Regulatory Agencies Fare Better: Regulatory agencies received higher levels 
of agreement that they would effectively manage any risks: 37% initially trusted 
OSHA, 38% trusted CPSC and 39% of participants initially agreed they would 
trust CDC to effectively manage risks.  
 
• More Information Changed Trust Levels:  After learning about 
nanotechnology and regulatory agency responsibilities, many study participants 
in the post-test moved away from the “don’t know” category.   The directions of 
these changes, however, varied.  
 
• Worse News for the Congress:  In the post-test answers, Congress fared 
worst on the question of trust: 63% disagreed or strongly disagreed that 
Congress would effectively manage any risks (27% agreed or strongly agreed 
that Congress would not; 10% said “don’t know”). In the post-learning answers, 
the White House fared better than Congress. Still, 43% of participants disagreed 
or strongly disagreed that the White House would effectively manage any risk 
(31% trusted the White House, in the post test, while 12% said “don’t know”).  
 
• Trust in EPA, OSHA, CPSC, and CDC Increased: Trust in a number of 
agencies rose after study respondents knew more about their responsibilities and 
about nanotechnology. 46% trusted CPSC; 45% trusted EPA; 50% trusted CDC; 
46% trusted OSHA.   Trust in OSHA is notably ambivalent in comparison to other 
agencies, however, as 40% also do not trust that agency to effectively manage 
any risks. 
 
• Trust in FDA and USDA Not as Certain: Agencies whose trust figures were 
lower after citizens learned about nanotechnology and regulatory responsibilities 
were FDA (43% did not trust and 13% don’t know, while 44% do trust) and 
USDA (45% did not trust, 16% don’t know, while 39% do trust).  In the 
discussion part of the study, concerns about FDA regulations were raised in all 
12 groups.  “FDA should not let companies put all kinds of stuff in food” 
commented one respondent.  Medical products were frequently given as 
examples where important risks emerged years after product release.  In 
addition, participants spoke about their low trust in FDA as related to perceived 
influence from Congress and industry, which they believed could undermine 
regulatory protections.   Taken together, the evidence points to FDA, and to a 
lesser extent, USDA, as significant nanotechnology regulatory concerns for 
citizens. 
 
Explaining more about public trust are the comments participants made about this 
issue in the group discussions. The group moderator synthesized these comments 
about the regulatory agencies in this conclusion: “Many participants trust the 
average agency employee to be honest and hardworking, but see the upper levels 
of agency management to be susceptible to political pressure and political 
control.” Despite mixed-to-negative views of some regulatory agencies, a 
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substantial proportion of participants also expressed that they “are glad the 
agencies exist, acknowledge their past contributions to society, and felt that the 
agencies at the very least are doing the best they can.” 
In the individual-level concerns expressed, participants further illuminated their 
feeling that politics negatively affects public safety. That “legislators try to undo 
environmental protections,” is one example.  
 
Strategies to Increase Public Trust in Nanotechnologies 
 
We also asked survey questions concerning ways government could work to increase 
public trust and whether people believed industry self-regulation would be sufficient (see 
Appendix, Tables 9, 10, and 11, respectively). 
 
• Voluntary Standards Insufficient:  The majority of study 
participants felt that voluntary standards applied by industry 
would not be sufficient. 55% said government control 
beyond voluntary standards is necessary, while 33% were 
unsure; 11% felt voluntary standards would be adequate. 
 
• More Safety Testing and Information Needed:  There was stro
agreement among participants concerning the most important ways
and industry could work to increase public trust. 71% of top choices
increased safety tests before products go to market, supplying more
to support informed consumer choices, and demonstrating how curr
regulation is sufficient to protect the environment and workers. 
 
• Tracking Risks of Products on the Market: “Better tracking risk
products already on the market” was the 4th-highest ranking choice 
both government and industry could work to increase public trust.  
 
Interest in Public Information and Education  
 
A strong thread of concern about public information is woven throughout th
group discussion data.  
 
• Consumers Want More Information:  Increasing consumers’ a
make informed choices was the 2nd most preferred way our respo
either government or industry could help to enhance the public’ tr
words, public information is a highly preferred mechanism either i
government should employ to increase public trust.  
• Lack of Information Breeds Suspicions: Group discussion stre
the lack of public information over and over again.  The group fac
noted that,  “The lack of public notification and information about
market status of nanotechnology products was also a major conce
these participants…The public not getting enough information is v
as an integrity issue since it creates a suspicion of government lyi
cover-ups. A strong minority opinion held that it is the public’s 
 14“Voluntary standards, 
possible risks, and 
bureaucrats: That’s a red 
flag for me.”ng 
 government 
 were for 
 information 
ent 
s related to 
for ways 
e survey and 
bility to 
ndents said 
ust. In other 
ndustry or 
ssed 
ilitator 
 the 
rn of 
iewed 
ng and 
responsibility to get involved and educate themselves…The key element 
to building trust between regulatory agencies and the public is open 
access to information, as well to separate the regulatory process from 
political control.” 
• No Information on Long-term Effects: The moderator observed that 
“Participants were disturbed that so little information about long-term 
health effects of nanotechnological products, particularly consumables, is 
available even though products are coming out on the market. This was 
true of environmental effects as well.” One respondent keyed in on this 
as a concern: “You aren’t talking about the long terms effects and what 
is known. Why?”  
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APPENDICIES 
 
1.  DATA TABLES, NANOTECHNOLOGY AND PUBLIC TRUST 2005 
 
Table 1. Initial Knowledge of Nanotechnnology 
 
 How much would you say you 
know about nanotechnology?  
Pre-
Test 
 a lot 2.8 
  some 16.9 
  a little 26.0 
  nothing 54.2 
  Total 100.0 
 
 
Table 2. Knowledge Re “Next Industrial Revolution” 
 
“Nanotechnology is predicted to 
be the next industrial revolution” Pre-test
 true 24.3 
  don't know 75.1 
  Not true .6 
  Total 100.0 
 
 
Table 3. Sources of Knowledge on Nanotechnology 
 
 
All 
Sources 
If 
Information 
From 1 
Source 
If 
Information 
From 2 
Sources 
If 
Information 
From 3 Sources 
ads  2.9 4.1  3.6 
children's TV  2.9 2.0 5.6 2.4 
specials public TV or 
radio  17.6 22.4 11.1 17.9 
commercial TV or radio 
news  11.2 14.3 5.6 11.9 
magazines  17.1 8.2 27.8 17.9 
newspaper articles  10.0 8.2 8.3 11.9 
trade or professional 
journals  8.2 6.1 11.1 8.3 
science fiction books or 
stories  12.4 10.2 13.9 13.1 
talk with another 
person  16.5 20.4 16.7 13.1 
Internet  .6 2.0   
 16
school  .6 2.0   
Total  100.0 100.0 100.0 100.0 
Note. Respondents were allowed to identify all relevant sources of learning about 
nanotechnology. The frequency with which each source type was mentioned is classifed 
above in relation to three classes of informed respondents.  
 
 
Table 4. Attitudes in Pre- and Post-Test 
 
 
Pre-
Study 
 
Post-
Test 
 quite positive 7.9 9.6 
  mostly positive 13.0 40.1 
  neutral 37.9 32.2 
  mostly negative .6 9.6 
  don't know 40.7 2.8 
 Missing data  .6 
  Total 100.0 2.8 
Significant change: Pearson Chi-Square=84.092, df = 24, p = .000 
 
 
Table 5. Expectations: Will Benefits Exceed Risks?  
 
  Pre-Study
Post-
Test 
 benefits will exceed risks 15.8 40.7 
  risks will exceed benefits 5.1 15.3 
  risks & benefits equal 13.6 29.9 
  don't know 65.0 14.1 
   .6  
  Total 100.0 100.0 
 
 
Table 6. Should Nanotechnology Products be Banned Until Further Study?  
 
Should new nanotechnology 
products be banned for the 
time being?  Pre-Study 
Post-
Study  
  agree to total ban 6.2 8.5 
  Ban is overreacting 35.6 75.7 
  Don't know 57.1 15.8 
  Missing data .1  
  Total 100.0 100.0 
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Table 7. Trust in Regulatory Agencies and Political Entities, Pre- and Post-Test 
 
% CDC 
 
 
EPA 
 
 
CPSC OSHA FDA USDA 
 
WHITE 
HOUSE 
 
 
CONGRESS 
strongly 
agree 
9.6 
(9.6) 
7.9 
(6.2) 
6.8 
(6.2) 
6.2 
(9.0) 
6.8 
(6.2) 
6.8 
(6.2) 
5.6 
(4.5) 
7.3 
(2.8) 
agree 29.4 
(40.1) 
23.2 
(39.0) 
29.4 
(40.1) 
30.5 
(36.7) 
24.3 
(36.7) 
23.7 
(32.8) 
23.2 
(26.6) 
18.1 
(23.7) 
don't  
know 
42.4 
(14.1) 
41.8 
(14.1) 
43.5 
(15.3) 
40.1 
(14.0) 
42.4 
(13.0) 
45.8 
(16.4) 
32.8 
(12.4) 
35.0 
(10.2) 
disagree 14.7 
(27.1) 
19.8 
(29.4) 
15.3 
(27.7) 
19.2 
(29.9) 
19.8 
(32.8) 
18.1 
(33.3) 
26.0 
(34.5) 
27.1 
(41.2) 
strongly 
disagree 
3.4 
(9.0) 
6.8 
(10.2) 
4.5 
(9.6) 
3.4 
(10.2) 
6.2 
(11.3) 
5.1 
(11.3) 
11.9 
(21.5) 
12.4 
(21.5) 
Missing 
data 
0.6 
(0) 
(0.6) 
(1.2) 
(0.6) 
(1.2) 
0.6 
(0) 
0.6 
(0) 
0.6 
(0) 
(0.6) 
(0.6) 
(0.6) 
(0.6) 
*Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
Note. Pre-test percentages are given first in each column; directly below are 
percentages of the post-test answers, in brackets (FDA 6.8% strongly agree in pre-test, 
6.2%, etc.).  
 
 
Table 8. Post-Test Summary Percentages, Trust in Regulatory Agencies and Political 
Entities 
 
%  CDC 
 
EPA 
 
CPSC 
 
OSHA
 
FDA 
 
USDA 
 
WHITE 
HOUSE 
 
CONGRESS 
Strongly 
agree or 
agree 
50 46 46 46 43 39 31 27 
Don't know 14 14 15 14 13 16 12 10 
Disagree or 
strongly 
disagree 
36 39 38 40 44 45 56 63 
Total 100 99* 99* 100 100 100 99* 100 
All percentages are rounded. *The designated percentages do not round to 100 due to a 
higher percentage of missing data for that entity. 
 
 
 
 
 18
Table 9. Can Industry Self-Regulation Be Sufficient?  
 
Answer choices % agreement 
I feel government control beyond voluntary standards 
is necessary 55.4 
I am not sure how I think about this 32.8 
I feel voluntary standards would be adequate 10.7 
Missing data 1.1 
Total 100.0 
Note. This was a post-test question only, assuming that only an informed public could 
give a useful answer to the question.  
 
 
Table 10. Preferred Ways Government Could Increase Public Trust  
 
Preferred Ways Government Could Increase Public 
Trust Percent 
increase safety tests before market 34.5 
supply more product information so people can 
choose 24.9 
show how regulatory practices are sufficient 11.9 
track better the product risks in market 9.6 
allow industry to be more self regulating 8.5 
no top choice (multiple answers) 3.4 
other (write in answers) 3.4 
nothing needs to be done 2.3 
be more hands off in regulating industry 1.7 
Total 100.0 
Note. The same answer choices were available for both industry and government, with 
the exception of the “hands off” answer; the opportunity to write in any other answers 
was also available in both cases.  
 
 
Table 11. Preferred Ways Industry Could Increase Public Trust 
 
Preferred Ways Industry Could Increase Public 
Trust Percent 
  increase safety test before going to market 28.2
  supply more information so people can choose 28.2
  voluntarily use higher safety standards 19.2
  track risks in market better 13.0
  show how current reg practices are sufficient 6.8
 19
  nothing needs to be done 1.7
 Missing data 1.7
  Other (write in answers) 1.1
  Total 100.0
Note. The same answer choices were available for both industry and government, with 
the exception of the “hands off” answer shown in Table 10; the opportunity to write in 
any other answers was also available in both cases.  
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2. Study Design 
 
Study Method 
To investigate concerns of an informed public and the effect of nanotechnology 
development scenarios, the study used a 3 by 4 quasi-experimental design. Quasi-
experiments are field experiments in which one variable is controlled, while all others 
are left to vary as they naturally occur (Cook & Campbell, 1979; Shadish, Cook, & 
Campbell, 2002).  
In each of 3 regional sites, participants were presented with one of 4 scenarios. Each 
scenario depicted a particular pathway for nanotechnology development, or 4 different 
scenarios, represented in written briefing materials. There was no expectation that 
stimuli such as the briefing materials might inherently cause a particular type of public 
response. Rather, the assumption was that participants would draw on existing values 
and knowledge in combination with the new information, and the conclusions reached 
thus could be usefully contrasted with those of the uninformed public.  
A pre- and post-test survey questionnaire was used to gathered data on attitudes 
towards nanotechnology, trust in government to manage risks, and participant 
demographics. Data also was collected on individual concerns, expressed privately, as 
well as on anticipated benefits, in two separate steps, after participants read the briefing 
information. After providing information on concerns and benefits, each group also 
talked with each other about nanotechnology; the discussion thus forms a third source 
of information on participants’ perceptions of nanotechnology and government.  
 
Procedures 
 
Study participants were brought together in quasi-experimental groups (4 experimental 
conditions) at each of 3 study locations. Although groups were used in the study, they 
were experimental groups rather than focus groups. Focus groups are essentially group 
interviews (e.g., Krueger, 1994), whereas individual-level data was sought for this study. 
Experimental groups were used for efficiency and control: individuals could read the 
experimental materials in their group settings to control for knowledge that might 
otherwise be gained between recruitment and exposure to experimental materials. 
Fifteen individuals representative of local demographics were recruited for each group. 
 
Each group of participants first completed an entry or pre-test questionnaire. Individuals 
then read their experimental materials, and next, were asked to silently consider and 
record three or four concerns they might have about nanotechnology. Each concern was 
recorded by participants on a 5”x7” card, along with their personal reason or reasons for 
that concern. After time allowed to express concerns, individuals were then asked to 
silently consider and record the benefits of nanotechnology they most anticipated. After 
providing individual concerns and reasons, each group then spent about 40 minutes 
discussing concerns and expected benefits, and the roles of regulatory agencies. A 
standardized 1.5 hours was allotted to each group.  
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Participants 
For this study, data was collected from individuals in experimental groups, where 
briefing materials were also distributed and read. Three different sized cities in the 
midwest, western, and southwestern regions of the U.S were chosen as sampling sites, 
both to discover attitudes that might be affected by regional economic and cultural 
variables, as well as to allow the sampling of a range of U.S. ethnicities, incomes, 
education levels, etc. Participants (N = 177) self assigned themselves randomly to the 
experimental conditions, without knowledge of doing so, by choosing group meeting 
times that fit their schedule. A professional firm conducted recruitment in the selected 
sites of Spokane, Washington; Dallas, Texas; and Cleveland, Ohio. (The 2004 study sites 
were in Raleigh-Durham, North Carolina; San Diego, California; and St. Paul-
Minneapolis, Minnesota.) Recruitment lists were randomly generated telephone number 
lists in selected zip codes and study participants were recruited to be fairly 
representative of local demographics (see Table 1 for a comparison of the participant 
sample to U.S. Census Bureau 2000 statistics). 
 
 
2005 Study Participants N = 177 
 Political 
Affiliation Gender % Race % 
Mean 
Income 
Mean 
Age EDU % 
 
 M F Cauc 
Afr.
Am. 
Hisp.
/ 
Latin
o 
Native 
Am. & 
Other 
   
Study 
Sample  
R=30% 
D=37% 
Ind=25% 
Other=8
% 
49.2 49.2 58.8 20.3 14.7 5.1  43 
HS=22* 
SC=26 
TRD/CER
T=10 
CD=23 
>CD=16 
 
2000 
US 
CENSU
S 
 49 51 77 13 4.2  50K 35.3 
HS=27 
SC=21 
CD=26 
>CD=9 
Abbreviations. Political affiliation: R=Republican, D=Democrat, Ind=Independent. EDU: 
HS = high school diploma, SC = some college, TRD = trade or certificate training 
beyond HS, CD = college degree, >CD = education beyond 4 year degree. *Less than 
HS = 2.3%. Missing data = 1.1%.  
 
 
Experimental conditions: briefing materials 
 
The briefing materials for each of the 4 experimental conditions were one-and-one-half 
to four pages in length and designed to be read in less than 20 minutes. The materials 
were written for the study by the author and reviewed, for clarity and accuracy, by 
several nanoscientists with a broad understanding of the subject, as well as by naïve 
readers. Two critical choices were made in development of the briefing material. The 
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first was a decision to develop the materials as a lay-written review of knowledge, to 
focus on facts and evidence relevant to nanotechnology and its development. This 
choice was based on results of a recent British study of media coverage of science 
(Hargreaves, Lewis, & Speers, 2003). That study’s authors concluded that journalists 
had contributed to public misunderstanding of science by reporting scientific controversy 
on childhood vaccinations, but not consistently reporting the evidence underlying the 
debate. This appears to have led to inaccurate British public perceptions about measles 
vaccinations and a purported link to autism. This link had been suggested by one study, 
but its results had not been replicable in subsequent studies. In this situation, the British 
public’s understanding accurately captured the controversy as portrayed by journalists, 
but that understanding was ill founded.  
 
A second important choice in developing the nanotechnology briefing materials was to 
explain nanoscience concepts by using metaphors that would be familiar to most people, 
in addition to using accurate scientific language. Using familiar metaphors is a teaching 
strategy that helps to make complex ideas accessible, and here, was intended to give 
adults with different education levels the greatest chance of absorbing the ideas. The 
status of nanotechnology was also represented by using many examples of current 
discoveries or existing applications, cited to the source in footnotes, for credibility.i The 
examples were gathered from nanoscience news sources and nanotechnology industry 
publications, and since nanotechnology is an international phenomenon, U.S. and 
international examples were used.  
 
Condition 1 materials presented basic information and an overview of nanotechnology 
applications in general. Condition 1 groups thus represent the least informed individuals 
in this study. Individuals in Condition 2 received basic information plus specific 
information on medical and industrial nanoresearch, and anticipated and actual current 
uses such as in cancer treatment or disease diagnosis, electronics, energy production, 
and environmental cleanup. Condition 2 materials also noted the potential convergence 
of medical biotechnology and nanotechnology. Condition 1 and 2 materials were 
replications of the 2004 Condition 1 and 2 materials, but had updated examples of 
nanotechnology products and supplied information on the regulatory and political bodies’ 
potential role in managing risks and benefits.  
 
Condition 3 materials focused on nanotechnology in consumable products such as 
cosmetics, food products, agriculture, personal care products, clothing, and so forth. 
Condition 4 materials discussed the anticipated convergence of nanotechnology, 
biotechnology, and uses to enhance the human body. Those applications include 
biopharming (use of genetically altered field crops to produce human insulin, etc.), 
regeneration of spinal cord and brain cells or limbs, and to enhance human mental 
functioning. Condition 4 materials were similar to those used in 2004 but presented 
updated information.  
 
Analyzing concerns 
 
Concerns were expressed privately by participants after they had read the briefing 
materials for their experimental condition. Multiple concerns about nanotechnology were 
allowed per person, up to a limit of four; the total number of concerns expressed was N 
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= 394, or about 2 per person. Practices of rigorous qualitative analysis (Eisenhardt, 
1989; Miles & Huberman, 1984; Yin, 1989) were followed to analyze concerns, which 
were classified by topical concern and then summarized quantitatively. Following Miles & 
Huberman’s recommended practices for cross-case analysis, first individual-level 
concerns were noted sequentially in a data log, for each group; no concerns were 
excluded. Each log entry retained as much as possible the citizens’ own words and 
focused on “the point” that was stressed. Concerns had been expressed on 5x7 cards. If 
a card held only the words “health effects,” that is, the log entry was simply those 
words. If a card held the question “How will this affect sensitive individuals?” concern for 
“effect on sensitive individuals” was recorded in the data log. Based on the log of 
concerns for each group, analysis focused on summarizing the local (statement level) 
subjects or issues.  
 
To rigorously summarize the concerns expressed, the author utilized knowledge about 
understanding others’ points and dialogue topics. That body of knowledge asserts that 
people understand others’ points by tracking the more general issue, called the “global” 
topic or subject (Cegala, Dewhurst, Galanes, Burggraf, Thorpe, Keyton, & Makay, 1989; 
Tracy, 1982, 1983; Reinhart, 1981). “Local” or statement level topics are made 
coherent, in a complex conversation, by their organization within global issues or topics, 
that is. Here, the strategy used was to group local concerns in more general, logical 
global concern groupings, to render the concerns intelligible as a whole, but retaining as 
well the individual voice that give the global topic labels greater meaning. For the same 
reason, the labels given to the subject or issue clusters are expressions used by 
individuals in the study.  
 
Example of Local Issues and Summary Global Issue 
General (global) versus Local (statement-level) expression of concern 
Long term health effects Long term risks of ultrafine pigments, nano 
cosmetics, wearing nanopants  
Breakthroughs that turn into disasters 
Biodegradable nanostructures’ effect on food chain 
 
 
Summaries were first produced for each group. The group summaries were then merged 
to produce a cross-case summary for each region, in order to locate shared concerns 
across all the groups. The most frequently mentioned concerns were not reduced further 
(military concerns and long term health concerns are two examples). Lower frequency 
concerns were reexamined and if possible, grouped under a slightly more general issue 
label, in order to retain the most concerns possible while reducing complexity to a 
manageable level. The focus of analysis at this level, thus, was on aggregating concerns 
as topical issues rather than on tracing arguments.ii Tracing arguments could be a valid 
way to understand premises and choices, but for this study, concerns or issues were 
investigated as global issues. The summarization process was intended to discover 
shared concerns across all participants. 
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i Sources for examining developing applications and research discoveries include industry 
magazines such as SmallTimes, on line at http://smalltimesmedia.com and Nanotechnology Now. 
Other sources regularly reporting nanoscience developments include Science Daily 
(www.sciencedaily.com), Nature, PR Newswire, The Age, and The Scientist. A historical narrative 
of nanotecology’s development is in Regis, E. (1995). Nano. The emerging science of 
nanotechnology: remaking the world-molecule by molecule. Boston: Little, Brown. 
 
ii Whereas a topic is the substantive subject of a sentence, paragraph, or discussion, an 
“argument” is a more complex feature of communication, as well as a term with multiple uses 
and meanings (O’Keefe, 1977). In O’Keefe’s formulation, “argument1” is defined as a statement-
level argument; “Jenny’s hair is red” is an example of argument1, a statement that makes an 
argument for or against something. “Argument2” locates a different sense of the term argument, 
where ‘argument’ is a type of interaction between several parties, an interactive exchange 
including claims, counterclaims, rebuttals, etc. In yet another common meaning of the term 
argument, the “argumentative case” is a complex line of argument (Rieke & Sillars, 1997). A line 
of argument is a collection of premises put forward by one author, making a case for a particular 
conclusion. 
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